Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes

J Nanobiotechnology. 2023 Mar 24;21(1):104. doi: 10.1186/s12951-023-01833-2.

Abstract

Non-small cell lung cancer (NSCLC) is the most common pathological type of LC and ranks as the leading cause of cancer deaths. Circulating exosomes have emerged as a valuable biomarker for the diagnosis of NSCLC, while the performance of current electrochemical assays for exosome detection is constrained by unsatisfactory sensitivity and specificity. Here we integrated a ratiometric biosensor with an OR logic gate to form an assay for surface protein profiling of exosomes from clinical serum samples. By using the specific aptamers for recognition of clinically validated biomarkers (EpCAM and CEA), the assay enabled ultrasensitive detection of trace levels of NSCLC-derived exosomes in complex serum samples (15.1 particles μL-1 within a linear range of 102-108 particles μL-1). The assay outperformed the analysis of six serum biomarkers for the accurate diagnosis, staging, and prognosis of NSCLC, displaying a diagnostic sensitivity of 93.3% even at an early stage (Stage I). The assay provides an advanced tool for exosome quantification and facilitates exosome-based liquid biopsies for cancer management in clinics.

Keywords: Clinical diagnostics; Exosomes; Non-small cell lung cancer; OR logic gate; Ratiometric biosensor.

MeSH terms

  • Biosensing Techniques
  • Blood Chemical Analysis / methods
  • Blood Chemical Analysis / standards
  • Carcinoma, Non-Small-Cell Lung* / blood
  • Carcinoma, Non-Small-Cell Lung* / diagnosis
  • Cell Line, Tumor
  • Electrochemistry*
  • Exome*
  • Humans
  • Limit of Detection